Wesfarmers proposes to acquire Australian Pharmaceutical Industries for $687 million
SYDNEY, AUSTRALIA: Wesfarmers Ltd has submitted a non-binding, indicative offer to acquire 100 percent of the shares outstanding in Australian Pharmaceutical Industries (API) for $1.38 per share by way of a scheme of arrangement, a news release said. The proposal price corresponds to a total equity value for Australian Pharmaceutical Industries (API) of approximately $687…